Skip to content
Policy Papers

The EveryLife Foundation Submits Comments on the Impacts of PFDD Meetings

Share this page

The EveryLife Foundation for Rare Diseases submitted comments in response to the FDA’s request for information on the impacts of Patient-Focused Drug Development (PFDD) meetings

Related Articles